Matthew Brams - Mar 4, 2024 Form 4 Insider Report for Cingulate Inc. (CING)

Role
EVP and Chief Medical Officer
Signature
/s/ Shane J. Schaffer, Attorney-in-Fact
Stock symbol
CING
Transactions as of
Mar 4, 2024
Transactions value $
$0
Form type
4
Date filed
3/6/2024, 06:00 PM
Previous filing
Mar 8, 2023
Next filing
Apr 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CING Stock Option (right to Buy) Award $0 +16.7K $0.00 16.7K Mar 4, 2024 Common Stock 16.7K $1.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date.